Literature DB >> 19877233

Assessing disease progression with MRI in atypical parkinsonian disorders.

Martin Köllensperger1, Gregor K Wenning.   

Abstract

During the last decade, novel MR techniques have become available to support the early differential diagnosis of Parkinsonism and also to generate MR surrogate markers of disease progression. The article reviews the current state of the art focusing on three atypical parkinsonian disorders: multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and dementia with Lewy bodies (DLB). Copyright 2009 Movement Disorder Society

Entities:  

Mesh：

Year:  2009        PMID： 19877233     DOI： 10.1002/mds.22582

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


  7 in total

Review 1.  Multiple system atrophy: a clinical and neuropathological perspective.

Authors:  Kiren Ubhi; Phillip Low; Eliezer Masliah
Journal:  Trends Neurosci       Date:  2011-09-29       Impact factor: 13.837

2.  Multiple system atrophy: current and future approaches to management.

Authors:  Olivier Flabeau; Wassilios G Meissner; François Tison
Journal:  Ther Adv Neurol Disord       Date:  2010-07       Impact factor: 6.570

3.  Progression of subcortical atrophy and iron deposition in multiple system atrophy: a comparison between clinical subtypes.

Authors:  Jae-Hyeok Lee; Tae-Hyung Kim; Chi-Woong Mun; Tae-Hyoung Kim; Yong-Hee Han
Journal:  J Neurol       Date:  2015-05-28       Impact factor: 4.849

4.  Resting bold fMRI differentiates dementia with Lewy bodies vs Alzheimer disease.

Authors:  J E Galvin; J L Price; Z Yan; J C Morris; Y I Sheline
Journal:  Neurology       Date:  2011-04-27       Impact factor: 9.910

Review 5.  New Imaging Markers for Movement Disorders.

Authors:  Christine Ghadery; Antonio P Strafella
Journal:  Curr Neurol Neurosci Rep       Date:  2018-04-03       Impact factor: 5.081

Review 6.  Modelling progressive autonomic failure in MSA: where are we now?

Authors:  Sylvia Stemberger; Gregor K Wenning
Journal:  J Neural Transm (Vienna)       Date:  2011-01-08       Impact factor: 3.575

7.  Treatment of multiple system atrophy using intravenous immunoglobulin.

Authors:  Peter Novak; Arlene Williams; Paula Ravin; Omar Zurkiya; Amir Abduljalil; Vera Novak
Journal:  BMC Neurol       Date:  2012-11-01       Impact factor: 2.474
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.